Paul Mampilly: Bubble in the Cryptocurrency Market

Over the last year, the electronic currencies which are referred to as cryptocurrencies have gone from an incredible niche industry to one who has had values in excess of $800 billion. Instead of being something that only hobbyists pursued it became something that many investors were incredibly interested in a very short period of time. Many of the people who invested in these cryptocurrencies less than one year ago have experienced returns on their investment that are in excess of 1000%. Obviously, such performance for these investments has generated incredible interest even from mainstream sources such as Wall Street. Visit to know more.

For this reason, Banyan Hill Publishing Company, one of the leading producers for investment advice columns, has recently asked all of their leading investment advice experts their opinion on the trends that are occurring in the cryptocurrency markets. Banyan Hill Publishing Company has published the work of Paul Mampilly for a number of years. Paul Mampilly originally gained a reputation as a successful investor during his time working on Wall Street. Paul Mampilly decided to eventually shy away from working on Wall Street in order to help every day Americans with investment by producing investment advice columns. He has recently published his viewpoints on the trends that are occurring in the cryptocurrency industry.

Paul Mampilly states that he sees the formation of a huge bubble in the cryptocurrency sector. This level is incredibly similar to the same one that occurred in the technology sector of the stock market in the late 1990s and early 2000 of the United States of America. While there are many individuals who have gained significant returns on their investment in the cryptocurrency industry over the last year all mentally believes that the market is poised to crash significantly in value in the near future.

As an investor in the stock market in the late 1990s, Paul Mampilly sold all of his stocks prior to the crash of the market. He cautions his readers who hold a significant investment in the cryptocurrency industry to do the same in order to minimize potential losses. While he does believe that many of these cryptocurrencies do represent a potential investment that could generate positive returns he believes that the technology is still too dumb to be considered a stable and reliable investment. Paul Mampilly believes that it is important to choose your investments after doing a large amount of research in order to ensure that you are not simply throwing money away.

Learn more:


Precision Medicine, Says Paul Mampilly, is the Hope for Investors and Patients

According to Paul Mampilly an investment advisor and editor of “Profits Unlimited” newsletter at Banyan Hill Publishing, Precision medicine is going to be the most profitable investment in the near future. He observes that precision medicine is going to bypass all drugs, medical devices, and vaccinations efforts even if they were all combined. Furthermore, it will revolutionize healthcare’s way of dealing with diseases. Paul Mampilly identified a mid-western company that is leading the charge in precision medicine saying their efforts will make it possible to treat current illnesses that are incurable. Visit the website to learn more.

Getting into the science of it, precision medicine involves looking at a person’s DNA and coming up with a medication that is specific to his genetic makeup. This will enable the medical practitioner to come up with custom-made medical interventions that rely on an individual’s DNA preventing diseases from spreading. He quotes diseases such as heart disease, Parkinson’s, and diabetes, all of which could be wiped out with the new technology.

Depending on a person’s genes, doctors can determine medications and treatments that will keep a given disease away, as well as if a disease is already set in, which treatments and medications will be effective to overcome it. Investors may be wondering how such a large industry involving a lot of companies is being called revolutionary by Paul Mampilly. Read this article at

Paul Mampilly says the mid-western company is the one to invest in because it has brought together some of the best scientific minds around the world to work in its facilities. He adds that the company is one of the leading firm in the industry in molecular diagnostic DNA sequencing in evaluating the likelihood of a person developing a particular disease. They, in turn, develop the best tailor-made drug therapy that a person will respond best to. To be specific, the company is interested in various forms of cancers, for instance ovarian, uterine, breast, and prostate, as well as rheumatoid arthritis.

The mid-western company has been identified as Myriad Genetics (MYGN) in Salt Lake City, Utah. It is a personalized medicine and diagnostic company dealing with sale and processing of cancer risk tests that identify specific cancer variants. Myriad Genetics tests show how a disease has progressed and treatment efficacy. Although their tests are not only for cancer screening, they show mutations that increase a person’s chances of developing cancer which is countered by early-stage interventions. Since Paul Mampilly announced this in September last year, the company stocks then valued at $1.5 billion have risen to a value of $2.2 billion.